Pinnacle Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Pinnacle Advisory Group's BMY Position: Q1 2021 in Review
Pinnacle Advisory Group opened a new position in Bristol-Myers Squibb (BMY) in Q1 2021: 5,091 shares worth $321K. The stake represents 0.01% of the portfolio and ranks #198 among its holdings. This is a return to the name: Pinnacle Advisory Group previously reported a position in BMY as recently as Q4 2015.
Pinnacle Advisory Group first reported a position in BMY in Q4 2015 and has held it in 2 quarters since. 2,370 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- Pinnacle Advisory Group held 5,091 shares of Bristol-Myers Squibb worth $321K as of Q1 2021.
- Bristol-Myers Squibb was a new Pinnacle Advisory Group position in Q1 2021.
- Bristol-Myers Squibb made up 0.01% of Pinnacle Advisory Group's portfolio in Q1 2021, its #198 holding.
- Pinnacle Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 2 quarters since.
- 2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on Pinnacle Advisory Group's 13F filing for Q1 2021, filed 12 May 2021.